Literature DB >> 21686735

Lymphatic system anomalies in Crouzon syndrome.

Pierre Bourgeois1, Stéphane Moniotte.   

Abstract

Crouzon syndrome is a rare genetic disorder characterised mainly by distinctive malformations of the skull and facial region and caused by mutations in the fibroblast growth factor receptor 2 (FGFR2) gene. No study reported on oedemas related to lymphatic system abnormalities in these patients. A case of Crouzon syndrome displaying classic facial anomalies but also with bilateral lower limb oedema is reported in whom lymphoscintigraphic investigation of the limbs clearly delineated the presence of lymphatic system anomalies.

Entities:  

Year:  2009        PMID: 21686735      PMCID: PMC3030293          DOI: 10.1136/bcr.07.2008.0586

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  6 in total

Review 1.  Congenital craniofacial anomalies of ophthalmic importance.

Authors:  P D Fries; J A Katowitz
Journal:  Surv Ophthalmol       Date:  1990 Sep-Oct       Impact factor: 6.048

2.  Anomalies of thoracic lymph duct drainage demonstrated by lymphoscintigraphy and review of the literature about these anomalies.

Authors:  P Bourgeois; D Munck; F Sales
Journal:  Eur J Surg Oncol       Date:  2007-06-25       Impact factor: 4.424

3.  Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea.

Authors:  Hajime Kubo; Renhai Cao; Ebba Brakenhielm; Taija Mäkinen; Yihai Cao; Kari Alitalo
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-17       Impact factor: 11.205

4.  The diagnosis and management of primary lymphedema.

Authors:  N L Browse
Journal:  J Vasc Surg       Date:  1986-01       Impact factor: 4.268

5.  Dose-dependent response of FGF-2 for lymphangiogenesis.

Authors:  Lynn K Chang; Guillermo Garcia-Cardeña; Filip Farnebo; Michael Fannon; Emy J Chen; Catherine Butterfield; Marsha A Moses; Richard C Mulligan; Judah Folkman; Arja Kaipainen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-02       Impact factor: 11.205

6.  Mutations in the third immunoglobulin domain of the fibroblast growth factor receptor-2 gene in Crouzon syndrome.

Authors:  M Oldridge; A O Wilkie; S F Slaney; M D Poole; L J Pulleyn; P Rutland; A D Hockley; M J Wake; J H Goldin; R M Winter
Journal:  Hum Mol Genet       Date:  1995-06       Impact factor: 6.150

  6 in total
  1 in total

1.  Extremely severe scoliosis, heterotopic ossification, and osteoarthritis in a three-generation family with Crouzon syndrome carrying a mutant c.799T>C FGFR2.

Authors:  Meina Lin; Yongping Lu; Yu Sui; Ning Zhao; Ying Jin; Dongxu Yi; Miao Jiang
Journal:  Mol Genet Genomic Med       Date:  2019-07-18       Impact factor: 2.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.